Effects of a topical hemostatic agent on an epistaxis model in rabbits

Current Therapeutic Research - Clinical and Experimental

Volumn 71, Issue 2, 2010, Pages 105-110

  Kurtaran, Hanifi ^a   Ark, Nebil ^a   Serife Ugur, K ^a   Sert, Huseyin ^a   Ozboduroglu, Akin Altug ^a   Kosar, Ali ^a   Gunduz, Mehmet ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

Author keywords

Ankaferd BloodStopper; Epistaxis; Experimental; Hemostasis

Indexed keywords

ANKAFERD BLOODSTOPPER; HEMOSTATIC AGENT; ISOTONIC SOLUTION; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALPINIA; ALPINIA OFFICINARUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLEEDING TIME; CONTROLLED STUDY; DISEASE DURATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; GLYCYRRHIZA GLABRA; GRAPE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; THYME; URTICA DIOICA;

EID: 77951963055     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2010.03.003     Document Type: Article

References (16)

1. Vaiman M, Eviatar E, Segal S The use of fibrin glue as hemostatic in endonasal operations: A prospective, randomized study. Rhinology. 2002, 40:185-188.
2. Pollice PA, Yoder MG Epistaxis: A retrospective review of hospitalized patients. Otolaryngol Head Neck Surg. 1997, 117:49-53.
3. Rubin Grandis J, Parnes SM, Dibiase PA, et al. The Management of Epistaxis 1999, American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Va. 3rd ed.
4. Chiu T, Dunn JS An anatomical study of the arteries of the anterior nasal septum. Otolaryngol Head Neck Surg. 2006, 13:33-36.
5. Wurman LH, Sack JG, Flannery JV, Lipsman RA The management of epistaxis. Am J Otolaryngol. 1992, 13:193-209.
6. Josephson GD, Godley FA, Stierna P Practical management of epistaxis. Med Clin North Am. 1991, 75:1311.
7. Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract, Ankaferd blood stopper. J Int Med Res. 2008, 36:163-170.
8. Kosar A, Cipil HS, Kaya A, et al. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model. Blood Coagul Fibrinolysis. 2009, 20:185-190.
9. Bilgili H, Kosar A, Kurt M, et al. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model. Med Princ Pract. 2009, 18:165-169.
10. Kurt M, Disibeyaz S, Akdogan M, et al. Endoscopic application of Ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report. Am J Gastroenterol. 2008, 103:2156-2158.
11. Kurt M, Kacar S, Onal IK, et al. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008, 40(Suppl 2):E262.
12. Ibis M, Kurt M, Onal IK, Haznedaroglu IC Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd Blood Stopper. J Altern Complement Med. 2008, 14:1073-1074.
13. Kurt M, Oztas E, Kuran S, et al. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med. 2009, 27:631.
14. European Commission Directive 86/609/EEC on Protection of Animals Used for Experimental and other Scientific Purposes 1986, European Commission, EU DG Environment, Brussels, Belgium.
15. Singer AJ, McClain SA, Katz A A porcine epistaxis model: Hemostatic effects of octylcyano-acrylate. Otolaryngol Head Neck Surg. 2004, 130:553-557.
16. Cipil HS, Kosar A, Kaya A, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009, 15:270-276.